Creating a blood sample repository for patients with interstitial lung diseases
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
This study is collecting blood samples from people with interstitial lung diseases, pneumonia, and healthy individuals to help researchers learn more about these conditions and find better treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 635 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT03478826 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a biospecimen repository by collecting blood samples from patients diagnosed with interstitial lung diseases (ILD), as well as from patients with pneumonia and healthy individuals for comparison. The goal is to gather a total of 500 samples from ILD patients to facilitate future research into potential biomarkers associated with these conditions. By analyzing these samples, researchers hope to gain insights that could lead to improved understanding and treatment of ILD.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with interstitial lung disease, pneumonia, or healthy individuals willing to participate.
Not a fit: Patients who are unwilling or unable to provide blood samples will not benefit from this study.
Why it matters
Potential benefit: If successful, this repository could enhance the development of biomarkers that improve diagnosis and treatment options for patients with interstitial lung diseases.
How similar studies have performed: Other studies have successfully established biospecimen repositories for various diseases, indicating that this approach is viable and could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia * Patients willing to provide written informed consent Exclusion Criteria: * Unwillingness/unable to give blood samples
Where this trial is running
Rochester, Minnesota
- Mayo Clinic — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Eva M Carmona Porquera, MD, PhD — Mayo Clinic
- Study coordinator: Michael Stachowitz
- Email: Stachowitz.Michael@mayo.edu
- Phone: 507-284-4862
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.